Clinical Trial

An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates our team's urology-specific AI (UroMed AI Doctor) for its safety, professionalism, knowledge and Q\&A ability, and tests its effectiveness against traditional manual urology care, to confirm if it can be a safe auxiliary tool and improve patients' preoperative experience. Before the study, we will test the AI with urology questions, compare it to international AI models (DeepSeek, ChatGPT, Google Gemini), and have two senior chief physicians evaluate it. In the clinical trial, patients at The First Affiliated Hospital of Guangxi Medical University will be randomly split into two groups: AI-assisted care or traditional care by a specialist. Two senior specialists will evaluate both groups blindly; each group will get preoperative education (AI or physician), with anxiety and satisfaction surveyed. Subsequently, a multi-center validation will be conducted with 11 domestic and international hospitals.
Trial Details
NCT Number NCT07555756
Lead Sponsor First Affiliated Hospital of Guangxi Medical University
Conditions Kidney Calculi, Prostatic Hyperplasia, Urinary Bladder Neoplasms
Enrollment 1,080 participants
Start Date 2026-05-01
Primary Completion 2029-04-30 (estimated)
Study Completion 2029-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-29